AzTrials
AzTrials

Substance UseNCT07042451

An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

A study testing Pink Cloud in people with Substance Use, run by Loyola Marymount University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Substance Use
What is being tested?
Pink Cloud
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,410 participants
Where
1 siteUnited States
Study dates
9 Jul 2025to Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participant is 18 years of age or older
  • Participant is willing to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
  • Participant owns a personal smartphone with cellular service
  • Participant is a permanent resident of the United States
  • Participant feels comfortable reading and understanding written English in everyday situations
  • Participant has consumed alcohol and/or used drugs (excluding tobacco or prescribed medication) at some point in their life, but not within the past couple of days
Show all 10Show fewer
  • Participant is not currently attending outpatient or residential treatment for substance and/or alcohol use
  • Participant does not have a plan to enter substance and/or alcohol treatment in the next 30 days
  • Participant has been invited by the research team to either the intervention or control condition and redeemed their subscription code.
  • Informed consent is provided

Who cannot join

  • Participant is younger than 18 years of age
  • Participant is unwilling to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week
  • Participant does not own a personal smartphone with cellular service
  • Participant is not a permanent resident of the United States
  • Participant does not feel comfortable reading and understanding written English in everyday situations
  • Participant has consumed alcohol or used drugs (excluding tobacco or prescribed medication) within the past couple of days
Show all 11Show fewer
  • Participant has never consumed alcohol or used drugs
  • Participant is currently attending outpatient or residential treatment for substance and/or alcohol use
  • Participant has a plan to enter substance and/or alcohol treatment in the next 30 days
  • Participant was not invited by the research team or did not redeem their assigned subscription code
  • Informed consent is not provided

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Joseph LaBrie, Ph.D. contact

3103385238

jlabrie@lmu.edu

United States1 site, 1 recruiting
  • Loyola Marymount

    Los Angeles, California, 90045

    Bradley M Trager, PhD, 3103383701, bradley.trager@lmu.edu

    Joseph W LaBrie, PhD, 3103385238, jlabrie@lmu.edu

    Recruiting

Other trials in United States

About this study

Official title: Digital Aftercare Assessed: An Evaluation of the Pink Cloud Application in Post-Treatment Substance Use Disorder Support

This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with features such as a sobriety counter, daily planner, and personal inventory tools. In this study, 1,410 participants in various stages of recovery will be randomly assigned to receive either access to the Pink Cloud app or to a control condition. Participants will complete follow-up assessments at 1, 3, and 6 months. Primary outcomes include number of days sober and frequency of drug and alcohol problems. Secondary outcomes include meeting attendance, proportion of sober individuals in one's social network, and engagement in recovery-related activities. The investigators hypothesize that participants in the Pink Cloud group will report more days sober and fewer substance use problems than those in the control group, and that they will also report attending more meetings, having a greater proportion of sober peers, and engaging more frequently in recovery activities.

Conditions
Substance Use
Being tested
Pink Cloud, Active Control
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pink CloudBehavioural

    Participants randomized to the Pink Cloud condition will receive a subscription code to access the Pink Cloud mobile application for approximately 365 days. The app includes features such as a searchable database of over 245,000 12-Step meetings (in-person and virtual), a sobriety counter, customizable daily planners, personal inventory tools, and a resentment journal. Participants are encouraged to use the app as they see fit throughout the study period. No prompts or required usage schedules will be imposed; instead, engagement will be self-directed to reflect real-world usage patterns.

  • Active ControlBehavioural

    Participants randomized to the control condition will receive a code to access recovery-related resources hosted on a private study website. These materials include links to mutual-help groups, crisis support services, and educational content and treatment options. Participants may access the website at their discretion and engage with the resources as often and in whatever ways they choose. No prompts or required usage schedules will be imposed.

Study groups in NCT07042451
Study groupRoleWhat they receive
Pink CloudExperimentalParticipants in this arm will receive access to a mobile application designed to support ongoing recovery from substance and alcohol use disorders. The app includes tools that promote engagement with 12-Step recovery principles and offer self-monitoring features. Participants can integrate the app into their recovery efforts as they see fit throughout the study period.
Receives: Behavioral: Pink Cloud
Active ControlActive comparatorParticipants in this arm will receive access to a website containing curated recovery-related materials. These resources are intended to offer general support for individuals in recovery, without emphasizing any specific program or approach. Participants are free to explore and use the content as they choose.
Receives: Behavioral: Active Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in sobriety status between baseline and 1 month

    Self-reported number of days participant reports not using alcohol or drugs in the past 30 days.

    Measured: baseline, 1 month

  2. Change in sobriety status between baseline and 3 months

    Self-reported number of days participant reports not using alcohol or drugs in the past 90 days.

    Measured: baseline, 3 months

  3. Change in sobriety status between baseline and 6 months

    Self-reported number of days participant reports not using alcohol or drugs in the past 180 days.

    Measured: baseline, 6 months

  4. Change in alcohol and drug problems between baseline and 1 month

    Self-reported frequency of alcohol and drugs problems in the past 30 days.

    Measured: baseline, 1 month

  5. Change in alcohol and drug problems between baseline and 3 months

    Self-reported frequency of alcohol and drugs problems in the past 90 days.

    Measured: baseline, 3 months

  6. Change in alcohol and drug problems between baseline and 6 months

    Self-reported frequency of alcohol and drugs problems in the past 180 days.

    Measured: baseline, 6 months

Secondary outcomes (9)
  1. Change in meeting attendance between baseline and 1 month

    Frequency of 12-Step / peer-to-peer meetings attended in the past 30 days.

    Measured: baseline, 1 month

  2. Change in meeting attendance between baseline and 3 months

    Frequency of 12-Step / peer-to-peer meetings attended in the past 90 days.

    Measured: baseline, 3 months

  3. Change in meeting attendance between baseline and 6 months

    Frequency of 12-Step / peer-to-peer meetings attended in the past 180 days.

    Measured: baseline, 6 months

  4. Change in social network between baseline and 1 month

    Proportion of social network that is sober in the past 30 days.

    Measured: baseline, 1 month

  5. Change in social network between baseline and 3 months

    Proportion of social network that is sober in the past 90 days.

    Measured: baseline, 3 months

  6. Change in social network between baseline and 6 months

    Proportion of social network that is sober in the past 180 days.

    Measured: baseline, 6 months

  7. Change in recovery related activities between baseline and 1 month

    Frequency of engagement with recovery related activities during the past 30 days.

    Measured: baseline, 1 month

  8. Change in recovery related activities between baseline and 3 months

    Frequency of engagement with recovery related activities during the past 90 days.

    Measured: baseline, 3 months

  9. Change in recovery related activities between baseline and 6 months

    Frequency of engagement with recovery related activities during the past 180 days.

    Measured: baseline, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2025
  2. Study start9 Jul 2025
  3. Primary completionJul 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
1,410 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07042451
Sponsor's protocol ID
R44DA061662
Status last verified
Sep 2025
First submitted
20 Jun 2025
Last updated
11 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Pink Cloud in people with Substance Use, run by Loyola Marymount University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joseph LaBrie, Ph.D. (3103385238, jlabrie@lmu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in sobriety status between baseline and 1 month (time frame: baseline, 1 month). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in